Al's Comment:

  This is a great tool. All Optune users should use it to monitor their compliance.   There is a big dose response curve, showing that people who use it over 90% of the time do the best and it is a big effect. See https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342854/ for details.  So 90% should be the target and try to go even higher!


Posted on: 06/02/2020

Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!